In This Edition

Key Takeaways

Remdesivir became the first FDA-approved COVID-19 drug.  Eurozone economic recovery slips, heightening expectations for a double-dip recession.  US President Trump and challenger Biden sparred in the final presidential debate, offering opposing visions for America.

Condition Updates

A rundown of important global developments in markets, in business, and region-by-region, as well as statistical risk assessments by country and by US state.

Implications of US-Russia New START

Over the past week, the US and Russia appear to have avoided a total collapse of the arms control agreement known as “New Start.”  Both Washington and Moscow continue to make incremental steps towards a year-long extension of the Obama-era agreement, indicating it is in neither country’s interest to let the treaty expire as scheduled in February 2021.    

COVID-19 and Effective Face Masks

Over the many months of the pandemic, researchers have been able to test and study the efficacy of different types of masks, giving the public a better understanding of mask wearing than when COVID-19 first began spreading. 

Download the Article